Recurrent varicella following steroids and fingolimod in a multiple sclerosis patient

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 5, 2013, Pages 1059-1061

  Ferraro, D ^a   De Biasi, S ^b   Vitetta, F ^a   Simone, A M ^a   Federzoni, L ^a   Borghi, V ^b   Cossarizza, A ^b   Nichelli, P F ^a   Sola, P ^a  

^a Nuovo Ospedale S Agostino   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BETA INTERFERON; FINGOLIMOD; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; NATALIZUMAB; PREDNISONE; STEROID;

ABDOMEN; ADAPTIVE IMMUNITY; ADULT; ANAPHYLAXIS; ANTIBODY TITER; ANTIVIRAL THERAPY; ARM; ATAXIC GAIT; CASE REPORT; CELL CULTURE; CHICKENPOX; CYTOFLUOROMETRY; DISABILITY; DRUG MEGADOSE; DRUG WITHDRAWAL; EXPANDED DISABILITY STATUS SCALE; FEMALE; HEMIPARESIS; HOSPITALIZATION; HUMAN; LETTER; LEUKOPENIA; LYMPHOCYTOPENIA; MIDDLE AGED; MULTIPLE SCLEROSIS; PAPULAR RASH; PRIORITY JOURNAL; RECURRENT INFECTION; REGULATORY T LYMPHOCYTE; RELAPSE; REPEAT PROCEDURE; SEROLOGY; STEROID THERAPY; TRUNK; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION;

CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROPYLENE GLYCOLS; SPHINGOSINE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84891371142     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9510-4     Document Type: Letter

References (10)

1. Aandahl EM, Michaëlsson J, Moretto WJ et al (2004) Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78:2454-2459
2. Cohen JA, Barkhof F, Comi G et al (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362:402-415
3. Hill G, Chauvenet AR, Lovato J et al (2013) Recent steroid therapy increases severity of varicella in children with acute lymphoblastic leukemia. Pediatrics 116:e525-e529
4. Li S, Gowans EJ, Chougnet C et al (2008) Natural regulatory T cells and persistent viral infection. J Virol 82:21-30
5. Ratchford JN, Costello K, Reich S et al (2012) Varicella Zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. Neurology 79:2002-2004
6. Ricklin ME, Lorscheider J, Waschbisch A et al (2013) T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology 81:1-8
7. Seissler N, Schmitt E, Hug F et al (2012) Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR + -Treg-cells in transplanted patients. Transpl Immunol 27:157-161
8. Serpero LD, Filaci G, Parodi A, et al (2013) Fingolimod modulates peripheral effector and regulatory T cells in MS patients. J Neuroimmune Pharm (Epub 2013 May 7). doi: 10.1007/s11481-013-9465-5
9. Suvas S, Kumaraguru U, Pack CD et al (2003) CD4+ CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198:889-901
10. Verstraeten T, Jumaan AO, Mullooly JP et al (2003) A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics 112:e98-e103